Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 19, 2020 - Issue 9
Submit an article Journal homepage
576
Views
10
CrossRef citations to date
0
Altmetric
Review

Long-term drug treatment in multiple sclerosis: safety success and concerns

Dejan Jakimovskia Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USAORCID Iconhttps://orcid.org/0000-0001-7114-4958View further author information
ORCID Icon,
Caila B Vaughnb Jacobs Comprehensive MS Treatment and Research Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences University at Buffalo, Buffalo, NY, USAView further author information
,
Svetlana Eckertb Jacobs Comprehensive MS Treatment and Research Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences University at Buffalo, Buffalo, NY, USAView further author information
,
Robert Zivadinova Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA;c Translational Imaging Center at Clinical Translational Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Stat37$e University of New York, Buffalo, NY, USAORCID Iconhttps://orcid.org/0000-0002-7799-1485View further author information
ORCID Icon &
Bianca Weinstock-Guttmanb Jacobs Comprehensive MS Treatment and Research Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences University at Buffalo, Buffalo, NY, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6732-151XView further author information
ORCID Icon
Pages 1121-1142 | Received 16 Jun 2020, Accepted 31 Jul 2020, Published online: 13 Aug 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Serena Ruggieri, Maria Esmeralda Quartuccio & Luca Prosperini. (2022) Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data. Degenerative Neurological and Neuromuscular Disease 12, pages 61-73.
Read now
Dejan Jakimovski, Svetlana P Eckert, Robert Zivadinov & Bianca Weinstock-Guttman. (2021) Considering patient age when treating multiple sclerosis across the adult lifespan. Expert Review of Neurotherapeutics 21:3, pages 353-364.
Read now

Articles from other publishers (8)

Christina Tryfonos, Eleni Pavlidou, Theofanis Vorvolakos, Olga Alexatou, Konstantinos Vadikolias, Maria Mentzelou, Gerasimos Tsourouflis, Aspasia Serdari, Georgios Antasouras, Sousana K. Papadopoulou, Exakousti-Petroula Aggelakou & Constantinos Giaginis. (2023) Association of Higher Mediterranean Diet Adherence With Lower Prevalence of Disability and Symptom Severity, Depression, Anxiety, Stress, Sleep Quality, Cognitive Impairment, and Physical Inactivity in Older Adults With Multiple Sclerosis. Journal of Geriatric Psychiatry and Neurology.
Crossref
Suyog Pol, Ravendra Dhanraj, Anissa Taher, Mateo Crever, Taylor Charbonneau, Ferdinand Schweser, Michael Dwyer & Robert Zivadinov. (2023) Effect of Siponimod on Brain and Spinal Cord Imaging Markers of Neurodegeneration in the Theiler’s Murine Encephalomyelitis Virus Model of Demyelination. International Journal of Molecular Sciences 24:16, pages 12990.
Crossref
Caila B Vaughn, Katelyn S Kavak, Dejan Jakimovski, Natasha Qutab, Robin Avila, Megan Vignos & Bianca Weinstock-Guttman. (2023) Patient-reported outcomes are the strongest predictors of disease disability in intramuscular interferon β-1a users. Neurodegenerative Disease Management 13:3, pages 151-159.
Crossref
Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini, Matilde Inglese, Francesco Patti, Carlo Pozzilli, Paolo Preziosa & Maria Trojano. (2022) Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion. Journal of Neurology 269:10, pages 5382-5394.
Crossref
Martin S. Weber, Mathias Buttmann, Sven G. Meuth, Petra Dirks, Erwan Muros-Le Rouzic, Julius C. Eggebrecht, Stefanie Hieke-Schulz, Jost Leemhuis & Tjalf Ziemssen. (2022) Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study. Frontiers in Neurology 13.
Crossref
Simona Halúsková & Martin Vališ. (2021) Treatment persistence to ocrelizumab and local experience. Neurologie pro praxi 22:3, pages 231-234.
Crossref
Dejan Jakimovski, Michael G Dwyer, Niels Bergsland, Bianca Weinstock-Guttman & Robert Zivadinov. (2021) Disease biomarkers in multiple sclerosis: current serum neurofilament light chain perspectives. Neurodegenerative Disease Management 11:4, pages 329-340.
Crossref
Paweł Grieb, Maciej Świątkiewicz, Agnieszka Kamińska, Anselm Jünemann, Robert Rejdak & Konrad Rejdak. (2021) Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis. Pharmaceuticals 14:4, pages 326.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.